Impact of pregnancy-associated plasma protein-A deletion on the adult murine skeleton

Journal of Bone and Mineral Research

Volumn 23, Issue 5, 2008, Pages 655-662

  Tanner, Sharon J ^a   Hefferan, Theresa E ^a   Rosen, Clifford J ^b   Conover, Cheryl A ^a  

^a MAYO CLINIC   (United States)

^b ST JOSEPH HOSPITAL   (United States)

Author keywords

BMD; Insulin like growth factor; Knock out mouse; Pregnancy associated plasma protein A; Skeletal physiology

Indexed keywords

BIOLOGICAL MARKER; METALLOPROTEINASE; PREGNANCY ASSOCIATED PLASMA PROTEIN A; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C;

ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; BONE DENSITY; BONE GROWTH; BONE MASS; BONE REMODELING; BONE STRENGTH; BONE TURNOVER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; FEMUR SHAFT; IN VIVO STUDY; KNOCKOUT MOUSE; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OSTEOPENIA; PROTEIN EXPRESSION; THICKNESS; TIBIA; TRABECULAR BONE; WILD TYPE;

ANIMALS; BONE AND BONES; BONE DENSITY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; POLYMERASE CHAIN REACTION; PREGNANCY PROTEINS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 42449120985     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.071210     Document Type: Article

References (41)

1. Rosen CJ 2004 Insulin-like growth factor I and bone mineral density: Experience from animal models and human observational studies. Clin Endocrinol Metab 18:423-435.
2. Conover CA 2000 Insulin-like growth factors and the skeleton. In: Canalis E (ed.) Skeletal Growth Factors. Lippincott Williams & Wilkins, Philadelphia, PA, USA, pp. 101-116.
3. Clemens TL, Chernausek SD 2004 Genetic strategies for elucidating insulin-like growth factor action in bone. Growth Horm IGF Res 14:195-199.
4. Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A 2001 Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 229:141-162.
5. Bikle D, Majumdar S, Laib A, Powell-Braxton L, Rosen C, Beamer W, Nauman E, Leary C, Halloran B 2001 The skeletal structure of insulin-like growth factor I-deficient mice. J Bone Miner Res 16:2320-2329.
6. Ogata N, Chikazu D, Kubota N, Terauchi Y, Tobe K, Azuma Y, Ohta T, Kadowaki T, Nakamura K, Kawaguchi H 2000 Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover. J Clin Invest 105:935-943.
7. Yakar S, Rosen CJ 2003 From mouse to man: Redefining the role of insulin-like growth factor-I in the acquisition of bone mass. Exp Biol Med 228:245-252.
8. Sjogren K, Sheng M, Moverare S, Liu J-L, Wallenius K, Tornell J, Isaksson O, Jansson J-O, Mohan S, Ohlsson C 2002 Effects of liver-derived insulin-like growth factor I on bone metabolism in mice. J Bone Miner Res 17:1977-1987.
9. Holly J, Perks C 2006 The role of insulin-like growth factor binding proteins. Neuroendocrinology 83:154-160.
10. Conover CA, Kiefer MC, Zapf J 1993 Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts: Insulin-like growth factor dependence and biological studies. J Clin Invest 91:1129-1137.
11. Mohan S, Nakao Y, Honda Y, Landale E, Leser U, Dony C, Lang K, Baylink DJ 1995 Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem 270:20424-20431.
12. Miyakoshi N, Richman C, Qin X, Baylink DJ, Mohan S 1999 Effects of recombinant insulin-like growth factor-binding protein-4 on bone formation parameters in mice. Endocrinology 140:5719-5728.
13. Zhang M, Faugere M-C, Malluche H, Rosen CJ, Chernausek SD, Clemens TL 2003 Paracrine overexpression of IGFBP-4 in osteoblasts of transgenic mice decreases bone turnover and causes global growth retardation. J Bone Miner Res 18:836-843.
14. Conover CA 1995 Insulin-like growth factor binding protein proteolysis in bone cell models. Prog Growth Factor Res 6:301-309.
15. Bunn RC, Fowlkes JL 2003 Insulin-like growth factor binding protein proteolysis. Trends Endocrinol Metab 14:176-181.
16. Durham SK, Kiefer MC, Riggs BL, Conover CA 1994 Regulation of insulin-like growth factor binding protein 4 by a specific insulin-like growth factor binding protein 4 proteinase in normal human osteoblast-like cells: Implications in bone cell physiology. J Bone Miner Res 9:111-117.
17. Oritz CO, Chen B-K, Bale LK, Overgaard MT, Oxvig C, Conover CA 2003 Transforming growth factor-β regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts. J Bone Miner Res 18:1066-1072.
18. Qin X, Byun D, Strong DD, Baylink DJ, Mohan S 1999 Studies on the role of human insulin-like growth factor-II (IGF-II)-dependent IGF binding protein (hIGFBP)-4 protease in human osteoblasts using protease-resistant IGFBP-4 analogs. J Bone Miner Res 14:2079-2088.
19. Miyakoshi N, Qin X, Kasukawa Y, Richman C, Srivastava AK, Baylink DJ, Mohan S 2001 Systemic administration of insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism. Endocrinology 142:2641-2648.
20. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG, Yates JR III, Conover CA 1999 The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 96:3149-3153.
21. Byun D, Mohan S, Yoo M, Sexton C, Baylink DJ, Qin X 2001 Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro. J Clin Endocrinol Metab 86:847-854.
22. Jia D, Heersche JNM 2005 Pregnancy-associated plasma protein-A proteolytic activity in rat vertebral cell cultures: Stimulation by dexamethasone - a potential mechanism for glucocorticoid regulation of osteoprogenitor proliferation and differentiation. J Cell Physiol 204:848-858.
23. Conover CA, Bale LK, Overgaard MT, Johnstone EW, Laursen UH, Fuchtbauer E-M, Oxvig C, van Deursen J 2003 Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Development 131:1187-1194.
24. Bale LK, Conover CA 2005 Disruption of insulin-like growth factor-II imprinting during embryonic development rescues the dwarf phenotype of mice null for pregnancy-associated plasma protein-A. J Endocrinol 186:325-331.
25. Modder UIL, Sanyal A, Kearns AE, Sibonga JD, Nishihara E, Xu J, O'Malley BW, Ritman EL, Riggs BL, Spelsberg TC, Khosla S 2004 Effects of loss of steroid receptor coactivator-1 on the skeletal response to estrogen in mice. Endocrinology 145:913-921.
26. Bouxsein ML, Myers KS, Shultz KL, Donahue LR, Rosen CJ, Beamer WG 2005 Ovariectomy-induced bone loss varies among inbred strains of mice. J Bone Miner Res 20:1085-1092.
27. Ackert-Bicknell CL, Rosen CJ 2007 A chromosomal inversion within a quantitative trait locus has a major effect on adipogenesis and osteoblastogenesis. Ann NY Acad Sci 1116:291-305.
28. Harrington SC, Simari RD, Conover CA 2007 Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet. Circ Res 100:1696-1702.
29. Adamo ML, Ma X, Ackert-Bicknell CL, Donahue LR, Beamer WG, Rosen CJ 2006 Genetic increase in serum insulin-like growth factor-I (IGF-I) in C3H/HeJ compared with C57BL/6J mice is associated with increased transcription from the IGF-I exon 2 promoter. Endocrinology 147:2944-2955.
30. Mohan S, Richman C, Guo R, Amaar Y, Donahue LR, Wergedal J, Baylink DJ 2003 Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms. Endocrinology 144:929-936.
31. Delahunty KM, Shultz KL, Gronowicz GA, Koczon-Jaremko B, Adamo ML, Horton LG, Lorenzo J, Donahue LR, Ackert-Bicknell C, Kream BE, Beamer WG, Rosen CJ 2006 Congenic mice provide in vivo evidence for a genetic locus that modulates serum insulin-like growth factor-I and bone acquisition. Endocrinology 147:3915-3923.
32. Brodt MD, Ellis CB, Silva MJ 1999 Growing C57Bl/6 mice increase whole bone mechanical properties by increasing geometric and material properties. J Bone Miner Res 14:2159-2166.
33. Qin X, Wergedal JE, Rehage M, Tran K, Newton J, Lam P, Baylink DJ, Mohan S 2006 Pregnancy-associated plasma protein-A increases osteoblast proliferation in vitro and bone formation in vivo. Endocrinology 147:5653-5661.
34. Jiang J, Lichtler AC, Gronowicz GA, Adams DJ, Clark SH, Rosen CJ, Kream BE 2006 Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling. Bone 39:494-504.
35. Mohan S, Baylink DJ 2005 Impaired skeletal growth in mice with haploinsufficiency of IGF-I: Genetic evidence that differences in IGF-I expression could contribute to peak bone mineral density differences. J Endocrinol 185:415-420.
36. Zhang M, Xuan S, Bouxsein ML, von Stechow D, Akeno N, Faugere MC, Malluche H, Zhao G, Rosen CJ, Efstratoados A, Clemens TL 2002 Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 277:44005-44012.
37. Zhao G, Monier-Faugere M-C, Langub MC, Geng Z, Nakayama T, Pike JW, Chernausek SD, Rosen CJ, Donahue L-R, Malluche HH, Fagin JA, Clemens TL 2000 Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: Increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 141:2674-2682.
38. Conover CA, Bale LK 2007 Loss of PAPP-A extends lifespan in mice. Aging Cell 6:727-729.
39. Mohan S, Baylink DJ 2002 Beyond carrier proteins: IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J Endocrinol 175: 19-31.
40. Mukherjee A, Rotwein P 2007 Insulin-like growth factor binding protein-5 in osteogenesis: Facilitator or inhibitor? Growth Horm IGF Res 17:179-185.
41. Rutter MM, Markoff E, Clayton L, Akeno N, Zhao G, Clemens TL, Chernausek SD 2005 Osteoblast-specific expression of insulin-like growth factor-1 in bone of transgenic mice induces insulin-like growth factor binding protein-5. Bone 36:224-231.